Investment
Features
FeesSafety
Academy
More
Pluang+

TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M.

Company Fundamentals
10 Sep 2026
PRNewsWire
View Source
Bullish
TransMedics appoints Fernando Araujo as CFO to drive growth, reiterates 2026 revenue guidance of $737-$757M.

TransMedics Group has named Fernando Araujo as its new Chief Financial Officer, effective September 21, 2026, succeeding Gerardo Hernandez who will focus on Latin America expansion. Araujo brings over 20 years of finance leadership from GE HealthCare and 3M, aligning with TransMedics' plans to scale operations and expand its organ transplant technologies globally. The company reaffirmed its 2026 revenue forecast of $737 million to $757 million, expecting 22% to 25% growth year-over-year. This leadership change supports TransMedics' strategy to grow its product pipeline and international presence while maintaining disciplined financial execution.

More News (TMDX)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App